Table 1 Patient characteristics
Number of patients | 35 |
|---|---|
Sex | |
Male (%) | 25 (71.4) |
Female (%) | 10 (28.6) |
Age (years) median range | 62.5 (45–81) |
Total cycles median (range) | 6 (5–8) |
Cumulative activity (GBq) median (range) | 44 (33.5–47) |
Primary tumor | |
Small intestinal (%) | 23 (65.7) |
Lungs (%) | 5 (14.3) |
Cancer of unknown primary (%) | 4 (11.4) |
Rectal (%) | 1 (2.9) |
Gastric (%) | 1 (2.9) |
Paraganglioma (%) | 1 (2.9) |
Ki-67 proliferation index | |
< 3% | 7 (20.0) |
3–20% | 22 (62.9) |
Not evaluable | 6 (17.1) |
Metastases (%) | |
Liver (%) | 31 (88.6) |
Lymph nodes (%) | 12 (34.3) |
Bone (%) | 12 (34.3) |
Peritoneal (%) | 7 (14.3) |